Seven Eight Capital, LP Vir Biotechnology, Inc. Transaction History

Seven Eight Capital, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$19.08 - $26.7 $225,296 - $315,273	-11,808 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$21.19 - $40.01 $250,211 - $472,438	11,808 New	11,808 $304,000
Q4 2021 Feb 14, 2022	SELL	$30.97 - $54.03 $370,308 - $646,036	-11,957 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$34.9 - $54.54 $417,299 - $652,134	11,957 New	11,957 $520,000
Q2 2021 Aug 13, 2021	SELL	$38.75 - $51.0 $1.04 Million - $1.37 Million	-26,894 Closed	0 $0
Q4 2020 Feb 09, 2021	BUY	$25.51 - $43.38 $686,065 - $1.17 Million	26,894 New	26,894 $720,000

219

87.4M

127K

1.19M

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $944M
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

Get notified when there are updates to the investment portfolio of Seven Eight Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Seven Eight Capital, LP with notifications on news.